Drug · DIN 02250462
LEVITRA
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since November 16, 2020; first marketed March 17, 2004.
- Drug Identification Number (DIN)
- 02250462
- Company (DIN owner)
- Bayer Inc.Elkhart, Indiana, United States
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Vardenafil G04BE09
- Class
- Human
- Record last updated
- June 15, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| VARDENAFIL (VARDENAFIL HYDROCHLORIDE) | 5 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- March 17, 2004: NOC 183New Drug Submission (NDS)
Recalls and safety alerts that mention it
Health Canada’s recall notices do not carry licence numbers, so these are matched by name: notices whose title or product names “levitra”. A notice may cover another product or only some lots: read it to see what it covers.
Other DINs named LEVITRA
- DIN 02250470 · Cancelled Post Market
- DIN 02250489 · Cancelled Post Market